1995 Results

People

  1. Kris
    Kris
  2. Motzer
    Motzer
  3. Scher
    Scher
  4. Saltz
    Saltz
  5. Schwartz
    Schwartz
  6. Hudis
    Hudis
  7. Kelsen
    Kelsen
  8. Rosen
    Rosen
  9. Marks
    Marks
  10. De Angelis
    De Angelis

Groups

  1. Department of Medicine (969)
  2. Solid Tumor Oncology Division (729)
  3. Surgery (289)
  4. GSK Faculty (287)
  5. Survivorship Research (260)
  6. Center for Hematologic Malignancies (230)
  7. Sloan Kettering Institute Faculty (227)
  8. Hematologic Malignancies, Division of (224)
  9. Genitourinary Oncology Service (203)
  10. Molecular Pharmacology and Chemistry Program Faculty (172)
  1. "antineoplastic agents"
Formats
  1. Journal Article (1901)
  2. Review (47)
  3. Conference Paper (23)
  4. Editorial (7)
  5. Research Letter (6)
  6. Guidelines (4)
  7. Book Section (3)
  8. Correspondence (2)
  9. Meeting Abstract (1)
  10. Miscellaneous (1)
Groups
  1. Department of Medicine (969)
  2. Solid Tumor Oncology Division (729)
  3. Surgery (289)
  4. GSK Faculty (287)
  5. Survivorship Research (260)
  6. Center for Hematologic Malignancies (230)

More Groups

People
  1. Mark Kris (77)
  2. Robert Motzer (70)
  3. Howard Scher (58)
  4. Gary Schwartz (52)
  5. Leonard Saltz (52)
  6. Ting-Chao Chou (50)

More People

Years
  1. 2025 (16)
  2. 2024 (65)
  3. 2023 (49)
  4. 2022 (49)
  5. 2021 (11)
  6. 2020 (4)

More Years

Publications
  1. Clinical Cancer Research (114)
  2. Journal of Clinical Oncology (111)
  3. Cancer (70)
  4. Seminars in Oncology (51)
  5. New England Journal of Medicine (43)
  6. Cancer Research (40)

More Publications

Publishers
  1. Elsevier Inc. (240)
  2. American Association for Cancer Research (187)
  3. Springer (175)
  4. American Society of Clinical Oncology (129)
  5. Wiley Blackwell (112)
  6. Nature Publishing Group (92)

More Publishers

Results (1995)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 1 study of weekly dosing of trastuzumab emtansine (T-DM1) in patients with advanced human epidermal growth factor 2-positive breast cancer
    Journal Article

    Beeram, M.; Krop, I. E.; Burris, H. A.; Girish, S. R.; Yu, W.; Lu, M. W.; Holden, S. N.; Modi, S.
    Cancer (2012)

    Fulltext@MSK | Save
  • Novel agents in invasive urothelial cancer
    Journal Article

    Balar, A. V.; Milowsky, M. I.
    Clinical Advances in Hematology & Oncology (2012)

    Fulltext@MSK | Save
  • Systematic classification and prediction of complications after nephrectomy in patients with metastatic renal cell carcinoma (RCC)
    Journal Article

    Silberstein, J. L.; Adamy, A.; Maschino, A. C.; Ehdaie, B.; Garg, T.; Favaretto, R. L.; Ghoneim, T. P.; Motzer, R. J.; Russo, P.
    BJU International (2012)

    Fulltext@MSK | Save
  • Cost effectiveness of concurrent gemcitabine and cisplatin with radiation followed by adjuvant gemcitabine and cisplatin in patients with stages IIB to IVA carcinoma of the cervix
    Journal Article

    Phippen, N. T.; Leath, C. A. 3rd; Chino, J. P.; Jewell, E. L.; Havrilesky, L. J.; Barnett, J. C.
    Gynecologic Oncology (2012)

    Fulltext@MSK | Save
  • When progressive disease does not mean treatment failure: Reconsidering the criteria for progression
    Journal Article

    Oxnard, G. R.; Morris, M. J.; Hodi, F. S.; Baker, L. H.; Kris, M. G.; Venook, A. P.; Schwartz, L. H.
    JNCI: Journal of the National Cancer Institute (2012)

    Fulltext@MSK | Save
  • Prostate cancer, version 3.2012
    Journal Article

    Mohler, J. L.; Armstrong, A. J.; Bahnson, R. R.; Boston, B.; Busby, J. E.; D'Amico, A. V.; Eastham, J. A.; Enke, C. A.; Farrington, T.; Higano, C. S.; more...
    Journal of the National Comprehensive Cancer Network (2012)

    Fulltext@MSK | Save
  • Five-year outcomes of adjuvant carboplatin/paclitaxel chemotherapy and intravaginal radiation for stage I-II papillary serous endometrial cancer
    Journal Article

    Kiess, A. P.; Damast, S.; Makker, V.; Kollmeier, M. A.; Gardner, G. J.; Aghajanian, C.; Abu-Rustum, N. R.; Barakat, R. R.; Alektiar, K. M.
    Gynecologic Oncology (2012)

    Fulltext@MSK | Save
  • Effectiveness of first-line management strategies for stage I follicular lymphoma: Analysis of the National Lymphocare Study
    Journal Article

    Friedberg, J. W.; Byrtek, M.; Link, B. K.; Flowers, C.; Taylor, M.; Hainsworth, J.; Cerhan, J. R.; Zelenetz, A. D.; Hirata, J.; Miller, T. P.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Clinical and histopathologic characteristics of rash in cancer patients treated with mammalian target of rapamycin inhibitors
    Journal Article

    Balagula, Y.; Rosen, A.; Tan, B. H.; Busam, K. J.; Pulitzer, M. P.; Motzer, R. J.; Feldman, D. R.; Konner, J. A.; Reidy-Lagunes, D.; Myskowski, P. L.; more...
    Cancer (2012)

    Fulltext@MSK | Save
  • How I treat hematologic emergencies in adults with acute leukemia
    Journal Article

    Zuckerman, T.; Ganzel, C.; Tallman, M. S.; Rowe, J. M.
    Blood (2012)

    Fulltext@MSK | Save